- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
6OU.2: 19 residues within 4Å:- Chain A: Q.940, E.941, Y.942, W.943, T.946, I.980, Y.981, I.984, L.987, V.1000, M.1001, I.1003, G.1004, K.1005, M.1007, V.1128, Q.1132
- Chain C: C.1097, V.1101
3 PLIP interactions:3 interactions with chain A- Hydrophobic interactions: A:W.943, A:I.984
- Hydrogen bonds: A:Y.942
6OU.6: 19 residues within 4Å:- Chain B: Q.940, E.941, Y.942, W.943, T.946, I.980, Y.981, I.984, L.987, V.1000, M.1001, I.1003, G.1004, K.1005, M.1007, V.1128, Q.1132
- Chain D: C.1097, V.1101
3 PLIP interactions:3 interactions with chain B- Hydrophobic interactions: B:W.943, B:I.984
- Hydrogen bonds: B:Y.942
6OU.10: 19 residues within 4Å:- Chain B: C.1097, V.1101
- Chain C: Q.940, E.941, Y.942, W.943, T.946, I.980, Y.981, I.984, L.987, V.1000, M.1001, I.1003, G.1004, K.1005, M.1007, V.1128, Q.1132
3 PLIP interactions:3 interactions with chain C- Hydrophobic interactions: C:W.943, C:I.984
- Hydrogen bonds: C:Y.942
6OU.14: 19 residues within 4Å:- Chain A: C.1097, V.1101
- Chain D: Q.940, E.941, Y.942, W.943, T.946, I.980, Y.981, I.984, L.987, V.1000, M.1001, I.1003, G.1004, K.1005, M.1007, V.1128, Q.1132
3 PLIP interactions:3 interactions with chain D- Hydrophobic interactions: D:W.943, D:I.984
- Hydrogen bonds: D:Y.942
- 4 x 01: primidone
01.3: 14 residues within 4Å:- Chain A: F.875, Y.878, T.879, Y.882, Y.911, L.915, K.919, D.947, R.985, D.988, I.989, F.1140, R.1143, P.1148
6 PLIP interactions:6 interactions with chain A- Hydrophobic interactions: A:F.875, A:Y.878, A:I.989, A:I.989
- Hydrogen bonds: A:Y.911
- pi-Stacking: A:F.1140
01.7: 14 residues within 4Å:- Chain B: F.875, Y.878, T.879, Y.882, Y.911, L.915, K.919, D.947, R.985, D.988, I.989, F.1140, R.1143, P.1148
6 PLIP interactions:6 interactions with chain B- Hydrophobic interactions: B:F.875, B:Y.878, B:I.989, B:I.989
- Hydrogen bonds: B:Y.911
- pi-Stacking: B:F.1140
01.11: 14 residues within 4Å:- Chain C: F.875, Y.878, T.879, Y.882, Y.911, L.915, K.919, D.947, R.985, D.988, I.989, F.1140, R.1143, P.1148
6 PLIP interactions:6 interactions with chain C- Hydrophobic interactions: C:F.875, C:Y.878, C:I.989, C:I.989
- Hydrogen bonds: C:Y.911
- pi-Stacking: C:F.1140
01.15: 14 residues within 4Å:- Chain D: F.875, Y.878, T.879, Y.882, Y.911, L.915, K.919, D.947, R.985, D.988, I.989, F.1140, R.1143, P.1148
6 PLIP interactions:6 interactions with chain D- Hydrophobic interactions: D:F.875, D:Y.878, D:I.989, D:I.989
- Hydrogen bonds: D:Y.911
- pi-Stacking: D:F.1140
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yin, Y. et al., Molecular basis of neurosteroid and anticonvulsant regulation of TRPM3. Nat.Struct.Mol.Biol. (2025)
- Release Date
- 2025-01-22
- Peptides
- Transient receptor potential cation channel, subfamily M, member 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
D - Membrane
-
We predict this structure to be a membrane protein.
- Coordinates
- PDB Format
- Method
- ELECTRON MICROSCOPY
- Oligo State
- homo-tetramer
- Ligands
- 8 x Y01: CHOLESTEROL HEMISUCCINATE(Non-covalent)
- 4 x 6OU: [(2~{R})-1-[2-azanylethoxy(oxidanyl)phosphoryl]oxy-3-hexadecanoyloxy-propan-2-yl] (~{Z})-octadec-9-enoate(Non-covalent)
- 4 x 01: primidone
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Yin, Y. et al., Molecular basis of neurosteroid and anticonvulsant regulation of TRPM3. Nat.Struct.Mol.Biol. (2025)
- Release Date
- 2025-01-22
- Peptides
- Transient receptor potential cation channel, subfamily M, member 3: ABCD
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
CC
BD
D - Membrane
-
We predict this structure to be a membrane protein.